跳转至内容
Merck
  • Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.

Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.

International journal of pharmaceutics (2015-03-01)
Ankita Shah, Abu T M Serajuddin
摘要

A novel method of greatly increasing solubility and dissolution rate of a model basic drug, haloperidol, by interacting it with water-soluble weak organic acids in aqueous media was previously reported in the literature. Amorphous solid dispersion (SD) was formed when solutions containing haloperidol and various acids were dried. However, the SDs were semisolid, viscous and sticky, especially when the drug load was high, and could not be processed into tablets. The drug release from SD was also incomplete since the viscous material did not readily mix with aqueous media. In the present study, a mesoporous metalosilicate, Neusilin(®) US2, was incorporated in SDs prepared by using malic, tartaric and citric acids. The silicate constituted 40% w/w of the total solid mass. The addition of silicate converted SDs into powders, which were then characterized for flow properties, bulk and tap density, and tabletability. Their physical properties were found to be acceptable for the development of tablets. DSC and powder XRD showed that haloperidol and acids converted completely to amorphous forms, and they did not show any sign of crystallization during accelerated stability study at 40°C/75% RH and 25°C/60% RH for 9 months. Complete drug release under gastrointestinal pH conditions could be obtained from tablets prepared.

材料
货号
品牌
产品描述

Sigma-Aldrich
无水柠檬酸粉末, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
DL-苹果酸, ReagentPlus®, ≥99%
Sigma-Aldrich
无水柠檬酸粉末, ≥99.5%, FCC, FG
Sigma-Aldrich
无水柠檬酸粉末, anhydrous, suitable for cell culture, suitable for plant cell culture
USP
无水柠檬酸粉末, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
无水柠檬酸粉末, BioUltra, anhydrous, ≥99.5% (T)
Sigma-Aldrich
无水柠檬酸粉末, ACS reagent, ≥99.5%
Sigma-Aldrich
硬脂酸镁, technical grade
Sigma-Aldrich
DL-苹果酸, 99%
Sigma-Aldrich
氟哌啶醇, powder
Sigma-Aldrich
无水柠檬酸粉末, 99%
USP
苹果酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
DL-苹果酸, ≥98% (capillary GC)
Sigma-Aldrich
2-羟基丁酸 钠盐, 97%
Supelco
柠檬酸, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
酒石酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
无水柠檬酸粉末, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Supelco
苹果酸, Pharmaceutical Secondary Standard; Certified Reference Material
USP
氟哌啶醇, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
DL-苹果酸, meets analytical specification of FCC, E296, 99-100.5% (alkalimetric)
Sigma-Aldrich
硬脂酸镁, puriss., meets analytical specification of Ph. Eur., BP, ≥90% stearic and palmitic acid basis, ≥40% stearic acid basis (GC), 4.0-5.0% Mg basis (calc on dry sub.)
Sigma-Aldrich
无水柠檬酸粉末, SAJ first grade, ≥99.5%
Supelco
无水柠檬酸粉末, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
苹果酸, meets USP/NF testing specifications
无水柠檬酸粉末, anhydrous, European Pharmacopoeia (EP) Reference Standard
Supelco
DL-苹果酸, analytical standard
氟哌啶醇, European Pharmacopoeia (EP) Reference Standard
系统适用性试验用氟哌啶醇, European Pharmacopoeia (EP) Reference Standard
峰鉴别用氟哌啶醇, European Pharmacopoeia (EP) Reference Standard